Fosun's Strategic Pivot: Core Business Focus and Global Expansion

In the ever-evolving business landscape, Fosun International, led by its Chairman Guo Guangchang, has been making strategic moves to focus on core businesses and expand its global footprint. As the company navigates the complexities of the global economy, it has demonstrated a commitment to operational excellence and innovation, positioning itself as a key player in the global market.



Fosun's strategic focus on core businesses has yielded significant results. In the first half of 2024, the company's total revenue amounted to RMB97.84 billion, with industrial operation profit reaching RMB3.47 billion. The four core subsidiaries—Yuyuan, Fosun Pharma, Fosun Insurance Portugal, and Fosun Tourism Group (FTG)—achieved a total revenue of RMB72.17 billion, accounting for 74% of the Group's total revenue. This steady growth in revenue is a testament to Fosun's commitment to its core businesses and the value they generate for the company and its stakeholders.

Fosun's globalization strategy has been a driving force behind its overseas revenue growth and market leadership. With a profound business presence in more than 35 countries and regions around the world, Fosun has successfully integrated different industries and resources in various countries and regions, enhancing the global operation capabilities of its member companies. This approach has enabled Fosun to tap into potential values and create mutual benefits for the company and its partners.

One notable example of Fosun's asset-light strategy and collaboration with key partners is the Taicang Alps Resort project. The phase II project, with a total investment of over RMB5 billion, is funded by the Taicang Municipal Government and operated and managed by FTG. This collaboration allows Fosun to leverage its operational capabilities to generate profits without the need for significant capital investment, while also contributing to the economic growth of the region.



Fosun's commitment to innovation and R&D has also played a crucial role in its success. The company invested RMB3.5 billion in technology innovation in the first half of 2024, focusing on cutting-edge technologies such as biopharmaceuticals and advanced medical devices. This investment in innovation is expected to drive future growth and profitability, further solidifying Fosun's position as a global innovation-driven consumer group.

In conclusion, Fosun's strategic focus on core businesses, asset-light strategy, and collaboration with key partners have created value and mutual benefits for the company and its partners. By leveraging its operational capabilities and investing in innovation, Fosun has successfully participated in global markets and achieved steady revenue growth. As the company continues to navigate the complexities of the global economy, it remains well-positioned to capitalize on opportunities and create value for its stakeholders.